[Conjugated linoleic acid improves glucose and lipid metabolism in diabetic mice].
PPARs
conjugated linoleic acid
diabetes
glycolipid metabolism
obesity
Journal
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
ISSN: 1673-4254
Titre abrégé: Nan Fang Yi Ke Da Xue Xue Bao
Pays: China
ID NLM: 101266132
Informations de publication
Date de publication:
30 Jun 2019
30 Jun 2019
Historique:
entrez:
5
7
2019
pubmed:
5
7
2019
medline:
30
8
2019
Statut:
ppublish
Résumé
To analyze the effect of conjugated linoleic acid (CLA) on glucose and lipid metabolism in obese diabetic (db/db) mice. db/db mice were randomized for treatment with saline or CLA mixture administered intragastrically. The changes in body weight, dietary intake, water intake, oral glucose tolerance, triglyceride and total cholesterol were recorded after the treatments. HE staining and oil red O staining were used to assess liver pathologies and fatty acid content. The expression levels of PPARα, PPARγ, CD36, CHREBP and SREBP-1c were detected using real-time PCR and Western blotting. HepG2 cells were treated with CLA and linoleic acid and the expressions of PPARα, ACC, P-ACC, and CD36 were detected; the level of acetyl-CoA in the cell supernatant was detected using ELISA. CLA treatment obviously reduced the dietary and water intake of db/db mice, effectively reduced the body weight and decreased serum triglyceride and cholesterol levels ( The mixture of two conjugated linoleic acid isomers can reduce fasting blood glucose, increase glucose tolerance and improve glycolipid metabolism in db/db mice by enhancing the expression of PPARα, increasing P-ACC and inhibiting CD36 expression.
Identifiants
pubmed: 31270056
doi: 10.12122/j.issn.1673-4254.2019.06.18
pmc: PMC6743911
doi:
Substances chimiques
Linoleic Acids, Conjugated
0
Triglycerides
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
chi
Sous-ensembles de citation
IM
Pagination
740-746Références
Gastroenterology. 2001 Apr;120(5):1183-92
pubmed: 11266382
Diabetes. 2004 Feb;53 Suppl 1:S43-50
pubmed: 14749265
FASEB J. 2005 Oct;19(12):1746-8
pubmed: 16055499
Am J Physiol Endocrinol Metab. 2012 Aug 15;303(4):E504-14
pubmed: 22693206
Evid Based Complement Alternat Med. 2014;2014:768540
pubmed: 25404949
Animal. 2018 Jul;12(7):1405-1412
pubmed: 29122042
Diabetes Care. 2007 May;30(5):1212-8
pubmed: 17277038
Biochem Soc Trans. 2014 Aug;42(4):1025-32
pubmed: 25109997
Proteomics. 2012 Feb;12(3):461-76
pubmed: 22144173
Br J Nutr. 2017 Dec;118(11):914-929
pubmed: 29173234
Nutrients. 2016 Mar 02;8(3):128
pubmed: 26950145
Curr Opin Cell Biol. 2015 Apr;33:125-31
pubmed: 25703630
J Nutr. 2002 May;132(5):940-5
pubmed: 11983818
J Nutr. 2000 May;130(5):1140-6
pubmed: 10801910
Am J Clin Nutr. 2004 Aug;80(2):279-83
pubmed: 15277146
Med Oncol Tumor Pharmacother. 1990;7(2-3):169-71
pubmed: 2232933
Diabet Med. 2005 May;22(5):612-8
pubmed: 15842517
Zhonghua Yi Xue Za Zhi. 2007 Aug 28;87(32):2249-52
pubmed: 18001543
Eur J Clin Invest. 2014 Jan;44(1):65-73
pubmed: 24134687
J Anim Sci. 2001 Mar;79(3):714-21
pubmed: 11263832
Diabetes Care. 2005 Apr;28(4):942-9
pubmed: 15793204
Metabolism. 1997 Oct;46(10):1140-5
pubmed: 9322796
J Agric Food Chem. 1999 May;47(5):1956-60
pubmed: 10552477
Diabetes. 2007 Mar;56(3):574-82
pubmed: 17327424
Annu Rev Nutr. 2002;22:505-31
pubmed: 12055356
J Viral Hepat. 2013 Mar;20(3):174-82
pubmed: 23383656
Diabetes Obes Metab. 2006 Mar;8(2):206-13
pubmed: 16448525